Prevention of inflammatory activation of human gestational membranes in an ex vivo model using a pharmacological NF-κB inhibitor

Journal of Immunology

Volumn 183, Issue 8, 2009, Pages 5270-5278

  Keelan, Jeffrey A ^a,c   Khan, Sadiqa ^a   Yosaatmadja, Francisca ^a   Mitchell, Murray D ^a,b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL9 CHEMOKINE; I KAPPA B; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; LIPOPOLYSACCHARIDE; MACROPHAGE DERIVED CHEMOKINE; PROSTAGLANDIN E2; SALAZOSULFAPYRIDINE; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TRANSCRIPTION FACTOR RELA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

AMNION; APOPTOSIS; ARTICLE; CELL FUNCTION; CHORION; CONTROLLED STUDY; CYTOKINE RELEASE; DECIDUA; EX VIVO STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; MEMBRANE TRANSPORT; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN MICROARRAY;

AMNION; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; CELL SURVIVAL; CYTOKINES; FEMALE; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; MODELS, BIOLOGICAL; PREGNANCY; PREGNANCY COMPLICATIONS; PROTEIN ARRAY ANALYSIS; SULFASALAZINE; TRANSCRIPTION FACTOR RELA;

EID: 77952334038     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0802660     Document Type: Article

References (50)

1. Behrman, R. A., and A. Stitch Butler. 2006. Preterm Birth: Causes, Consequences and Prevention. Natl. Acad. Press, Washington, DC.
2. Goldenberg, R. L., J. F. Culhane, J. D. Iams, and R. Romero. 2008. Epidemiology and causes of preterm birth. Lancet 371: 75-84.
3. Romero, R., J. Espinoza, L. F. Goncalves, J. P. Kusanovic, L. A. Friel, and J. K. Nien. 2006. Inflammation in preterm and term labour and delivery. Semin. Fetal Neonatal Med. 11: 317-326.
4. Goldenberg, R. L., W. W. Andrews, and J. C. Hauth. 2002. Choriodecidual infection and preterm birth. Nutr. Rev. 60: S19-S25.
5. Romero, R., O. Erez, and J. Espinoza. 2005. Intrauterine infection, preterm labor, and cytokines. J. Soc. Gynecol. Investig. 12: 463-465.
6. Keelan, J. A., M. Blumenstein, R. J. Helliwell, T. A. Sato, K. W. Marvin, and M. D. Mitchell. 2003. Cytokines, prostaglandins and parturition: a review. Placenta 24: S33-S46.
7. Zaga-Clavellina, V., H. Merchant-Larios, G. Garcia-Lopez, R. Maida-Claros, and F. Vadillo-Ortega. 2006. Differential secretion of matrix metalloproteinase-2 and -9 after selective infection with group B streptococci in human fetal membranes. J. Soc. Gynecol. Investig. 13: 271-279.
8. Andrews, W. W., R. L. Goldenberg, O. Faye-Petersen, S. Cliver, A. R. Goepfert, and J. C. Hauth. 2006. The Alabama Preterm Birth study: polymorphonuclear and mononuclear cell placental infiltrations, other markers of inflammation, and outcomes in 23- to 32-week preterm newborn infants. Am. J. Obstet. Gynecol. 195: 803-808.
9. Romero, R., R. Gomez, F. Ghezzi, B. H. Yoon, M. Mazor, S. S. Edwin, and S. M. Berry. 1998. A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition. Am. J. Obstet. Gynecol. 179: 186-193. (Pubitemid 28394494)
10. Yoon, B. H., C. W. Park, and T. Chaiworapongsa. 2003. Intrauterine infection and the development of cerebral palsy. BJOG 110(Suppl. 20): 124-127.
11. Seong, H. S., Y. D. Kang, S. I. E. Lee, S.-S. Shim, R. Romero, and B. H. Yoon. 2006. Lack of evidence for microorganisms in most women with clinical chorioamnionitis: a need to revisit the clinical and microbiologic criteria for one of the most important obstetrical complications. Am. J. Obstet. Gynecol. 195: S73.
12. Lee, S. E., R. Romero, C. W. Park, J. K. Jun, and B. H. Yoon. 2008. The frequency and significance of intraamniotic inflammation in patients with cervical insufficiency. Am. J. Obstet. Gynecol. 198: 633.e1-8.
13. Smulian, J. C., S. Shen-Schwarz, A. M. Vintzileos, M. F. Lake, and C. V. Ananth. 1999. Clinical chorioamnionitis and histologic placental inflammation. Obstet. Gynecol. 94: 1000-1005.
14. Lee, S. E., R. Romero, H. Jung, C. W. Park, J. S. Park, and B. H. Yoon. 2007. The intensity of the fetal inflammatory response in intraamniotic inflammation with and without microbial invasion of the amniotic cavity. Am. J. Obstet. Gynecol. 197: 294.e1-6.
15. Romero, R., F. Gotsch, B. Pineles, and J. P. Kusanovic. 2007. Inflammation in pregnancy: its roles in reproductive physiology, obstetrical complications, and fetal injury. Nutr. Rev. 65: S194-S202.
16. Romero, R., D. Lafreniere, G. W. Duff, N. Kadar, S. Durum, and J. C. Hobbins. 1987. Failure of endotoxin to cross the chorioamniotic membranes in vitro. Am. J. Perinatol. 4: 360-362. (Pubitemid 17146081)
17. Kent, A. S., M. H. Sullivan, and M. G. Elder. 1994. Transfer of cytokines through human fetal membranes. J. Reprod. Fertil. 100: 81-84. (Pubitemid 24100397)
18. Martinon, F., and J. Tschopp. 2005. NLRs join TLRs as innate sensors of pathogens. Trends Immunol. 26: 447-454.
19. Takada, H., and A. Uehara. 2006. Enhancement of TLR-mediated innate immune responses by peptidoglycans through NOD signaling. Curr. Pharm. Des. 12: 4163-4172.
20. Lu, Y. C., W. C. Yeh, and P. S. Ohashi. 2008. LPS/TLR4 signal transduction pathway. Cytokine 42: 145-151.
21. Greten, F. R., and M. Karin. 2004. The IKK/NF-κB activation pathway: a target for prevention and treatment of cancer. Cancer Lett. 206: 193-199.
22. Lindstrom, T. M., and P. R. Bennett. 2005. The role of nuclear factor κ B in human labour. Reproduction 130: 569-581.
23. Lappas, M., M. Permezel, H. M. Georgiou, and G. E. Rice. 2002. Nuclear factor κB regulation of proinflammatory cytokines in human gestational tissues in vitro. Biol. Reprod. 67: 668-673. (Pubitemid 34803959)
24. Koga, K., and G. Mor. 2007. Toll-like receptors and pregnancy. Reprod. Sci. 14: 297-299.
25. Lappas, M., K. Yee, M. Permezel, and G. E. Rice. 2005. Sulfasalazine and BAY 11-7082 interfere with the nuclear factor-κB and IκB kinase pathway to regulate the release of proinflammatory cytokines from human adipose tissue and skeletal muscle in vitro. Endocrinology 146: 1491-1497.
26. 2-IsoP in human gestational tissues. Free Radic. Biol. Med. 42: 1791-1796.
27. Vroom, F., E. N. van Roon, P. B. van den Berg, J. R. Brouwers, and L. T. de Jong-van den Berg. 2008. Prescribing of sulfasalazine, azathioprine and methotrexate round pregnancy: a descriptive study. Pharmacoepidemiol. Drug Saf. 17: 52-61.
28. Elovitz, M. A. 2006. Anti-inflammatory interventions in pregnancy: now and the future. Semin. Fetal Neonatal Med. 11: 327-332.
29. Barham, D., and P. Trinder. 1972. An improved colour reagent for the determination of blood glucose by the oxidase system. Analyst 97: 142-145.
30. Keelan, J. A., R. L. Zhou, and M. D. Mitchell. 2000. Activin A exerts both proand anti-inflammatory effects on human term gestational tissues. Placenta 21: 38-43.
31. Simpson, K. L., J. A. Keelan, and M. D. Mitchell. 1999. Labour-associated changes in the regulation of production of immunomodulators in human amnion by glucocorticoids, bacterial lipopolysaccharide and pro-inflammatory cytokines. J. Reprod. Fertil. 116: 321-327. (Pubitemid 29335552)
32. Namimatsu, S., M. Ghazizadeh, and Y. Sugisaki. 2005. Reversing the effects of formalin fixation with citraconic anhydride and heat: a universal antigen retrieval method. J. Histochem. Cytochem. 53: 3-11.
33. Bennett, P. R., G. V. Chamberlain, L. Patel, M. G. Elder, and L. Myatt. 1990. Mechanisms of parturition: the transfer of prostaglandin E2 and 5-hydroxyeicosatetraenoic acid across fetal membranes. Am. J. Obstet. Gynecol. 162: 683-687.
34. Nakla, S., K. Skinner, B. F. Mitchell, and J. R. Challis. 1986. Changes in prostaglandin transfer across human fetal membranes obtained after spontaneous labor. Am. J. Obstet. Gynecol. 155: 1337-1341.
35. Viscardi, R. M., C. K. Muhumuza, A. Rodriguez, K. D. Fairchild, C. C. Sun, G. W. Gross, A. B. Campbell, P. D. Wilson, L. Hester, and J. D. Hasday. 2004. Inflammatory markers in intrauterine and fetal blood and cerebrospinal fluid compartments are associated with adverse pulmonary and neurologic outcomes in preterm infants. Pediatr. Res. 55: 1009-1017.
36. Murthy, V., and N. L. Kennea. 2007. Antenatal infection/inflammation and fetal tissue injury. Best Pract. Res. Clin. Obstet. Gynaecol. 21: 479-489.
37. Sadowsky, D. W., K. M. Adams, M. G. Gravett, S. S. Witkin, and M. J. Novy. 2006. Preterm labor is induced by intraamniotic infusions of interleukin-1β and tumor necrosis factor-α but not by interleukin-6 or interleukin-8 in a nonhuman primate model. Am. J. Obstet. Gynecol. 195: 1578-1589.
38. Brennand, J. E., R. Leask, R. W. Kelly, I. A. Greer, and A. A. Calder. 1995. Changes in prostaglandin synthesis and metabolism associated with labour, and the influence of dexamethasone, RU 486 and progesterone. Eur. J. Endocrinol. 133: 527-533.
39. 2 across the fetal membrane before and after labor. Acta Obstet. Gynecol. Scand. 69: 399-403.
40. Mitchell, M. D., V. Goodwin, S. Mesnage, and J. A. Keelan. 2000. Cytokineinduced coordinate expression of enzymes of prostaglandin biosynthesis and metabolism: 15-hydroxyprostaglandin dehydrogenase. Prostaglandins Leukotrienes Essent. Fatty Acids 62: 1-5.
41. Rizek, R. M., C. S. Watson, S. Keating, H. H. Tai, J. R. Challis, and A. D. Bocking. 2007. 15-Hydroxyprostaglandin dehydrogenase protein expression in human fetal membranes with and without subclinical inflammation. Reprod. Sci. 14: 260-269.
42. Weber, C. K., S. Liptay, T. Wirth, G. Adler, and R. M. Schmid. 2000. Suppression of NF-κB activity by sulfasalazine is mediated by direct inhibition of IκB kinases α and β. Gastroenterology 119: 1209-1218.
43. Wahl, C., S. Liptay, G. Adler, and R. M. Schmid. 1998. Sulfasalazine: a potent and specific inhibitor of nuclear factor κB. J. Clin. Invest. 101: 1163-1174.
44. Connell, W., and A. Miller. 1999. Treating inflammatory bowel disease during pregnancy: risks and safety of drug therapy. Drug Saf. 21: 311-323.
45. Ishaq, S., and J. R. Green. 2001. Tolerability of aminosalicylates in inflammatory bowel disease. BioDrugs 15: 339-349. (Pubitemid 32634793)
46. Norgard, B., A. E. Czeizel, M. Rockenbauer, J. Olsen, and H. T. Sorensen. 2001. Population-based case control study of the safety of sulfasalazine use during pregnancy. Aliment. Pharmacol. Ther. 15: 483-486.
47. Rahimi, R., S. Nikfar, A. Rezaie, and M. Abdollahi. 2008. Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: a meta-analysis. Reprod. Toxicol. 25: 271-275.
48. Norgard, B., L. Pedersen, L. A. Christensen, and H. T. Sorensen. 2007. Therapeutic drug use in women with Crohn's disease and birth outcomes: a Danish nationwide cohort study. Am. J. Gastroenterol. 102: 1406-1413. (Pubitemid 46976292)
49. Urquhart, B. L., J. A. Ware, R. G. Tirona, R. H. Ho, B. F. Leake, U. I. Schwarz, H. Zaher, J. Palandra, J. C. Gregor, G. K. Dresser, and R. B. Kim. 2008. Breast cancer resistance protein (ABCG2) and drug disposition: intestinal expression, polymorphisms and sulfasalazine as an in vivo probe. Pharmacogenet. Genomics 18: 439-448.
50. Aye, I. L., J. W. Paxton, D. A. Evseenko, and J. A. Keelan. 2007. Expression, localisation and activity of ATP binding cassette (ABC) family of drug transporters in human amnion membranes. Placenta 28: 868-877.